Medical

pharmacon

Also found in: Dictionary, Wikipedia.

pharmacon

A nonspecific term for a drug, medicinal, pharmaceutical or other therapeutic preparation.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive
6 August 2014 - Norwegian company Biotec Pharmacon ASA (OSL:BIOTEC) said today it had received a US patent covering the usage of a combination of various monoclonal antibodies and yeast beta-glucan for the inventive treatment of a range of different cancers.
8 November 2011 - Norwegian company Biotec Pharmacon ASA (OSL:BIOTEC) said today its net loss melted to NOK5.4m in the third quarter of 2011 from NOK7.9m a year earlier.
Moreover, the modernist's cannibal imagery implies a willingness to ingest the "poison enemy" as a remedy, accepting the metaphorical risks and rewards of the post-jennerian Pharmacon. 5 Like a properly prepared and administered vaccine, this approach requires an anthological inoculation, as opposed to a wholesale, acritical consumption of foreign influences, be they cultural, ideological or scientific.
Thus, by degrees, the beach acquired in the popular mind the typically doubled and oxymoronic meaning of the pharmacon, a drug that can both heal and kill.
Companies Mentioned in this Report: Smith & Nephew Plc, Innocoll AG, Derma Sciences, Inc., Pfizer Inc., Premier Research Group Limited, CytoTools AG, Celgene Corporation, CardioVascular BioTherapeutics, Inc., Biotec Pharmacon ASA, Adocia
18 January 2012 - ArcticZymes AS, owned by Norwegian biopharmaceutical company Biotec Pharmacon ASA (OSL:BIOTEC), said Tuesday it had established a US subsidiary to service the North American research and molecular diagnostic market.
The parent company of ArcticZymes, Biotec Pharmacon ASA (OSL:BIOTEC), said Sunday it signed a non-exclusive supply agreement to deliver SAP to US company Affymetrix Inc (NASDAQ:AFFX).
M2 PHARMA-November 8, 2011-Biotec Pharmacon's Q3 2011 loss melts(C)2011 M2 COMMUNICATIONS
NORDIC BUSINESS REPORT-September 26, 2011--Biotec Pharmacon announces enzyme supply contract with Affymetrix(C)2011 M2 COMMUNICATIONS http://www.m2.com
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.